Matches 51 - 100 out of 205 < 1 2 3 4 5 >
Match Document Document Title
6291433 Derivatives of α-D-Thioxyloside and their use against atheroma  
The present invention concerns, as new industrial products, the α-D-xylose compounds of formula I: ##STR1## wherein X and Y represent, independently of one another, an oxygen atom or a sulphur...
6284744 Peritoneal induced medicaments  
A solution of hyaluronic acid and water-soluble salts thereof in a pharmaceutically acceptable media in which the hyaluronic acid concentration is at least about 0.4% by weight based on the weight...
6264913 Non-invasive test for assessing bacterial overgrowth of the small intestine  
Provided herein is a novel breath test for assessing bacterial overgrowth. The test involves administration of a labeled sorbitol or sorbitol derivative to a subject and measurement of the label in...
6258784 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation  
This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure ##STR1## wherein W is S, SO, SO 2 , NR; Y is O, S, NR, or CH 2 ; R is hydrogen or...
6235709 Inhibitor of helicobacter pylori colonization  
The present invention provides a safe and effective inhibitor of Helicobacter pylori colonization in the stomach and a food containing the inhibitor. The inhibitor of the present invention...
6224891 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions  
This invention relates to the treatment of diarrhea and related conditions caused by pathogenic E. coli infection. More specifically, this invention is drawn to the unexpected discovery that by...
6221350 Enhancement of microbial colonisation of the gastrointestinal tract  
Probiotic composition comprising one or more probiotic microorganisms, a carrier which will function to transport the one or more probiotic microorganisms to the large bowel or other regions of the...
6194393 Solution and solid-phase formation of glycosidic linkages  
The invention relates to methods that permit the rapid construction of oligosaccharides and other glycoconjugates. Methods for forming multiple glycosidic linkages in solution in a single step are...
6187768 Kit for flushing medical devices and method of preparation  
A kit and for flushing a medical device a method of preparing the kit is disclosed. The kit includes a container containing a mixed solution a unit dose of a pharmacologically effective amount of...
6187762 Polyvalent polymers for the treatment of rotavirus infection  
The present invention includes polymerizable monomers comprising a fucoside moiety. In one embodiment, the monomer has a polymerizable functional group, such as an olefinic bond, to which the...
6147054 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid  
A composition for cosmetic, pharmaceutical or dietetic use and including as the active ingredient, at least one of the substances which include acetylglucosamine and glucuronic acid in combination...
6143730 Preparation and use of sulfated oligosaccharides  
Sulfated oligosaccharides, wherein the oligosaccharide has the general formula I: R 1 --(R x ) n --R 2 (I) wherein R 1 and R 2 and each R x represents a...
6124266 Sulpholipid composition and methods for treating skin disorders  
The invention refers to the use of a sulpholipid SQDG having formula (I), wherein R 1 and R 2 , which are the same or different, are hydrogen or saturated or unsaturated, optionally...
6117843 Compositions for the treatment of acne containing clindamycin and benzoyl peroxide  
A pharmaceutical composition containing clindamycin and benzoyl peroxide is disclosed for the treatment of acne. The composition is stable for several months when stored at room temperature....
6103768 Fatty acid based compositions and methods for the control of plant infections and pests  
The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination...
6087339 Saccharide derivatives  
Disclosed are novel saccharide derivatives which inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. Additionally, disclosed...
6080726 Anti-viral and immuno stimulator polynucleotide duplex and use thereof  
A method of treating HSV-2 infection which comprises administering to a host subject to said infection an effective amount of a polynucleotide of the formula polyrI.polyr(C 12 U) where n is an...
6075010 Small molecular weight ligand-hexose containing clearing agents  
Small molecule weight clearing agents containing ligands such as biotin or biotin analogs and hexose residue, in particular galactose or N-acetyl galactosamine residues are taught. These clearing...
6063769 1-thiogalactose derivatives  
Disclosed are novel 1-thiogalactose derivatives which inhibit binding of heat labile toxin (LT) and/or chlorea toxin (CT) to cell surface receptors either in vitro or in vivo. Additionally,...
6013634 Solid support matrices containing a toxin binding oligosaccharide  
Disclosed are novel solid support matrices having a toxin-binding oligosaccharide covalently attached to a solid support through a linking arm which has at least 5 atoms separating the...
5998367 Pramlintide pro H-amylin salts and compositions  
Agonist analogues of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are...
5989592 Inhibition of complement pathway by sea cucumber fractions  
The present invention relates to methods for inhibiting the complement pathway in a mammal comprising administering an effective dose of a composition comprising an active ingredient selected from...
5985330 Inhibition of angiogenesis by sea cucumber fractions  
The present invention provides inhibition of angiogenesis in a warm-blooded animal by the administration of preparations isolated from the echinoderm sea cucumber (Class Holothuroidea). This...
5985826 Methods of using hepatic-directed compounds in pretargeting strategies  
Hepatic-directed compounds, reagents useful in making such compounds and associated methods and compositions are disclosed. Hepatic-directed compounds are processed by metabolic mechanisms, which...
5932554 1-galactose derivatives  
Disclosed are novel 1-galactose derivatives which inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. Additionally, disclosed...
5883079 Method for inhibiting H. pylori infection in mammalian tissue  
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I ...
5880111 Therapeutic derivations of diphosphonates  
Novel chemotherapeutic agents having utility in treating infectious diseases such as periodontal disease, certain urinary tract infections, and infectious urinary tract stones, are obtained by...
5849274 Stable light protection preparations containing surface-active glucose derivatives and water-soluble UV filters  
Cosmetic or pharmaceutical O/W emulsions which contain (a) one or more surface-active substances selected from the group consisting of glucose derivatives of the structural formula ##STR1## in...
5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic  
A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance.
5846943 Solid support matricles containing a toxin binding oligosaccharide  
Disclosed are novel solid support matrices having a toxin-binding oligosaccharide covalently attached to a solid support through a linking arm which has at least 8 atoms separating the...
5840702 Cystic fibrosis treatment  
The present invention provides a method of stimulating expression of a functional full-length cystic fibrosis transmembrane conductance regulator protein in an individual in need of such treatment,...
5837689 Sialyl lewis-x mimetics containing naphthyl backbones  
Compounds that possess selectin binding activity are described that have a three-dimensionally stable configuration for sialic acid and fucose, or analogs, derivatives, or mimics of these groups,...
5817634 Methods of treating diabetes mellitus and clycogen storage disease  
This present invention provides a method and compounds for priming the incorporation of cellular glucose into an oligosaccharide in a cell comprising administering to the cell a priming amount of a...
RE35904 Method and probes for detecting nucleoside transporter and method for producing the probes  
The present invention is directed to compounds capable of binding to the es nucleoside transporter of animal cells having the general formula: ##STR1## wherein n is 1-12; E is H, halogen, NH 2 ,...
5811405 Multiply fucosylated dicarboxylic acids possessing antiadhesive properties  
The invention relates to multiply fucosylated dicarboxylic acid derivatives possessing antiadhesive properties, to a process for preparing them, to their use, and to pharmaceuticals and diagnostic...
5807847 Nitrate esters  
Aliphatic Nitrate esters having a sulfur or phosphorus atom β or γ to a nitrate group having efficacy as vasodilators are described. Preferred nitrate esters may be synthesized by nitration of a...
5789385 Sialyl Lewis.sup.x mimetics containing phenyl backbones  
Compounds that possess selectin binding activity are described that have a three-dimensionally stable configuration for sialic acid and fucose, or analogs, derivatives, or mimics of these groups,...
5773424 Treatment of toxoplasmosis  
Pharmaceutical compositions comprising a pharmaceutical composition comprising a compound which is an α or β anomer, a D(+) or L(-) enantiomer of the following structural formula: ##STR1##...
5770585 Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal  
This invention is directed to a homogenous water-in-perfluorochemical stable liquid dispersion for acceptable therapeutic administration of a drug to the lung of an animal. The dispersion includes...
5767093 Methods for attenuating antibody-mediated xenograft rejection in human recipients  
Antibody-mediated xenograft rejection is attenuated by parenterally administering a xenoantibody-inhibiting amount of an identified carbohydrate xenoantigen to the recipient shortly before graft...
5753630 Method for treating and inhibiting gastric and duodenal ulcers  
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I ...
5750508 Sialic acid/fucose based medicaments  
Compounds that are synthetically inexpensive to make relative to the naturally occurring selectin ligands and that retain selectin binding activity are described that have a three-dimensionally...
5739115 Sulfated maltooligosaccharides with heparin-like properties  
A novel class of highly sulfated maltooligosaccharide having heparin-like activity is described, as well as methods for using these oligosaccharides to treat certain diseases including cancer, and...
5733886 Compositions of clindamycin and benzoyl peroxide for acne treatment  
Compositions suitable for the treatment of acne by topical application comprise clindamycin and benzoyl peroxide. Kits for preparing the compositions include a solution of clindamycin in a first...
5719192 Use of terbinafine for the therapeutic treatment of pneumocystosis  
A method of use comprising administering terbinafine for the primary and secondary prophylaxis and treatment of Pneumocystis carinii pneumonia, including oral administration of terbinafine at does...
5707653 Ulcer treating composition comprising sufalcrate and antibiotic  
Pharmaceutical compositions comprising an antibiotic adsorbed onto a disaccharide polysulfate-aluminum compound such as sucralfate are effective for the treatment of ulcers. The composition...
5702694 Compositions for treating corns, calluses and warts  
Topical compositions for the treatment of corns, calluses and warts comprising a benzenediol or a substituted 1,2-benzenediol and a pharmaceutically acceptable carrier, are described.
5700784 External preparation for skin  
An external preparation for the skin comprising at least one of the glycosides or hydroxysaliyclic acid and/or the glycosides of aliphatic esters of hydroxysalicylic acid represented by the...
5677285 Derivatives of neuraminic acid  
Provided are new derivatives of neuraminic acid of formula (I), where Ac represents an acyl residue of an aliphatic, araliphatic, aromatic, alicyclic, or heterocyclic carboxylic acid, including...
5665707 Treatment for toxoplasmosis with a composition comprising a lincosamide and a spiropiperidyl derivative of rifamycik S  
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or...
Matches 51 - 100 out of 205 < 1 2 3 4 5 >